Rxdx offering
Web2 days ago · NASDAQ: RXDX Last close prices updated as of Mar 31, 2024, 4:00 PM EST USD BATS BZX Real-Time Price Overview Key Ratios Trading Information Last Close 107.32 Sector Healthcare Industry... WebMar 11, 2024 · Prometheus Biosciences (RXDX) upsized its IPO size to offer 9M shares from earlier offered 7.35M shares planned in the last week; expected price range is between …
Rxdx offering
Did you know?
WebDec 9, 2024 · Prometheus Biosciences ( NASDAQ: RXDX) has priced an underwritten offering of 4,545,455 shares of its common stock at a price to the public of $110/share, for an expected gross proceeds of... WebDec 7, 2024 · SAN DIEGO, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision …
WebMar 22, 2024 · Prometheus Biosciences Inc (RXDX) stock is trading at $108.20 as of 1:22 PM on Wednesday, Mar 22, a decline of -$4.56, or -4.04% from the previous closing price of $112.76. The stock has traded between $107.23 and $112.42 so far today. Volume today is less active than usual. WebDec 9, 2024 · SAN DIEGO, Dec. 08, 2024 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
WebSAN DIEGO, March 09, 2024 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach … WebMar 12, 2024 · Prometheus Biosciences Inc. (NASDAQ: RXDX. SVB Leerink, Credit Suisse, Stifel and Guggenheim Securities are acting as joint bookrunning managers for the offering.
WebThe latest price target for Prometheus Biosciences ( NASDAQ: RXDX) was reported by Guggenheim on Monday, March 6, 2024. The analyst firm set a price target for 225.00 …
WebMar 28, 2024 · Prometheus Biosciences (RXDX) SVB Securities analyst Thomas Smith maintained a Buy rating on Prometheus Biosciences yesterday and set a price target of $160.00. The company’s shares closed last ... cscc race feesWebMay 9, 2024 · The aggregate gross proceeds from this offering are approximately $88.4 million, before deducting the underwriting discounts and commissions and estimated offering expenses. cscc recreation and wellnessWebThe latest price target for Prometheus Biosciences ( NASDAQ: RXDX) was reported by Guggenheim on Monday, March 6, 2024. The analyst firm set a price target for 225.00 expecting RXDX to rise... cscc program of studyWebAnalysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Prometheus Biosciences (RXDX) and Travere Therapeutics (TVTX) March 28, 2024TipRanks … cscc reading bankWebMar 12, 2024 · view all Offerings We are a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel … cscc programs of studyWebRXDX Stock Price - Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics. ... Not an offer or recommendation by Stocktwits. cscc rankingWebThis biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead. RXDX : 110.31 (+2.81%) PFE : 40.22 (-0.42%) TEVA : 8.73 … cscc preferred pathways